Cardio plus weights ranks best for cooling inflammation in metabolic syndrome

Metabolic syndrome, the cluster of risk factors including excess waist fat, high blood pressure and disturbed blood sugar and lipids, travels with chronic low-grade inflammation, and that inflammation is part of what makes the condition dangerous. Exercise is known to help, but the practical question for anyone planning their week is which kind: cardio, weights, or both. The comparative effectiveness of these modalities on inflammatory markers has remained poorly defined, which is exactly the gap this network meta-analysis set out to fill.

The researchers conducted a systematic review and network meta-analysis of 28 randomised controlled trials in patients with metabolic syndrome, comparing aerobic exercise, resistance training and combined training against control. The inflammatory markers examined were CRP, TNF-α and IL-6. Data were synthesised using random-effects models, and the exercise modalities were ranked against each other using a statistical ranking method called SUCRA, which estimates how likely each intervention is to be the best performer.

For CRP, combined training showed a significant reduction (standardised mean difference of 0.79 below control) and ranked top with a SUCRA of 86.8%, while aerobic exercise also reduced CRP significantly and resistance training showed a smaller effect. The CRP findings were rated moderate certainty with no publication bias detected. All modalities were associated with lower TNF-α, with combined training again showing the greatest effect, but those results were undermined by extreme disagreement between studies and significant publication bias. No modality reached significance for IL-6.

This analysis adds a useful ranking layer to the established finding that exercise lowers inflammation, suggesting the combination of cardio and resistance work sits at the top of the table for CRP. Its honest handling of evidence quality is as important as the ranking itself: the authors explicitly caution that the TNF-α and IL-6 results should be read sceptically. Open questions include why the resistance-only effect on CRP was smaller and whether longer or more standardised programmes would change the ordering.

For someone managing metabolic syndrome, or the risk factors that lead to it, the reliable part of this evidence points toward variety: the programmes that mixed aerobic and resistance training produced the most trustworthy drop in CRP, the inflammation marker doctors most commonly measure. It is a reason to think of cardio and weights as complementary rather than competing choices. The claims about other inflammatory markers rest on much shakier evidence, so they should not drive any decision on their own.